Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Prenetics Global (PRE) EBITDA (2021 - 2025)

Prenetics Global has reported EBITDA over the past 5 years, most recently at -$20.4 million for Q4 2025.

  • Quarterly EBITDA fell 65.77% to -$20.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$44.9 million through Dec 2025, changed 0.24% year-over-year, with the annual reading at -$44.5 million for FY2025, 22.64% down from the prior year.
  • EBITDA was -$20.4 million for Q4 2025 at Prenetics Global, down from -$6.2 million in the prior quarter.
  • Over five years, EBITDA peaked at $4.4 million in Q4 2022 and troughed at -$148.4 million in Q2 2022.
  • The 5-year median for EBITDA is -$11.9 million (2023), against an average of -$26.2 million.
  • The largest YoY upside for EBITDA was 105.17% in 2022 against a maximum downside of 1853.6% in 2022.
  • A 5-year view of EBITDA shows it stood at -$84.5 million in 2021, then surged by 105.17% to $4.4 million in 2022, then plummeted by 523.51% to -$18.5 million in 2023, then surged by 33.61% to -$12.3 million in 2024, then crashed by 65.77% to -$20.4 million in 2025.
  • Per Business Quant, the three most recent readings for PRE's EBITDA are -$20.4 million (Q4 2025), -$6.2 million (Q3 2025), and -$10.1 million (Q2 2025).